Shield Pharma LLC has been awarded a Phase I SBIR to develop its first compound. We hope to publish results next year.
1 thought on “Shield’s First SBIR”
Comments are closed.
Shield Pharma LLC has been awarded a Phase I SBIR to develop its first compound. We hope to publish results next year.
Comments are closed.
Hi, this is a comment.
To delete a comment, just log in and view the post's comments. There you will have the option to edit or delete them.